跳至主要内容
临床试验/NCT05621187
NCT05621187已完成不适用

BIO|MASTER.Pamira Study

Biotronik SE & Co. KG24 个研究点 分布在 8 个国家目标入组 221 人开始时间: 2022年11月30日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
221
试验地点
24
主要终点
Pamira lead related SADE-d free rate at 6 months after implantation

研究概览

简要总结

Confirm clinical safety and performance of the Pamira lead to support the regulatory post market strategy in Europe and other regions and validating promotional claims by

  • demonstrating clinical safety
  • evaluating performance based on sensing and pacing assessment
  • collecting additional data of interest to assess other aspects such as the handling and usability

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 99 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Standard indication for ICD or CRT-D therapy according to clinical guidelines
  • Planned for de novo implantation of a BIOTRONIK ICD or CRT-D in combination with Pamira
  • Ability to understand the nature of the study and willingness to provide written informed consent
  • Ability and willingness to perform all follow-up visits at the study site
  • Ability and willingness to use the CardioMessenger and acceptance the BIOTRONIK Home Monitoring® concept

排除标准

  • Mechanical tricuspid valve prosthesis or a severe tricuspid valve disease
  • Known Dexamethasone acetate intolerance
  • Cardiac surgical post-implantation procedure planned within 12 months (including interventional procedures like ablation, valve replacement, heart transplant etc.)
  • Less than 18 years old
  • Pregnant or breast feeding
  • Participating in another interventional clinical investigation
  • Life-expectancy less than 12 months

结局指标

主要结局

Pamira lead related SADE-d free rate at 6 months after implantation

时间窗: 6 months

次要结局

  • 2a and 2b: Rate of appropriate right ventricular sensing at the 6- and 12-month follow-up(6 months, 12 months)
  • 3a and 3b: Rate of appropriate right ventricular pacing at the 6- and 12-month follow-up(6 months, 12 months)
  • 1a and b: Pamira lead related SADE-d free rate at 3 and 12 months after implantation(3 months, 12 months)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (24)

Loading locations...

相似试验